A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours

N Fazio, R Buzzoni, E Baudin, L Antonuzzo, R A Hubner, H Lahner, W.W. de Herder, M Raderer, A Teule, J Capdevila, SK Libutti, MH Kulke, M Shah, D Dey, S Turri, P Aimone, C Massacesi, C Verslype

Research output: Contribution to journalArticleAcademicpeer-review

78 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)713-719
Number of pages7
JournalAnticancer Research
Volume36
Issue number2
Publication statusPublished - 2016

Research programs

  • EMC MM-01-39-01

Cite this